Histological grade of differentiation of hepatocellular carcinoma: Comparison of the efficacy of diffusion-weighted MRI with T2-weighted imaging and angiography-assisted CT

Journal of Medical Imaging and Radiation Oncology

Volumn 56, Issue 3, 2012, Pages 261-269

  Saito, Kazuhiro ^a   Moriyasu, Fuminori ^a   Sugimoto, Katsutoshi ^a   Nishio, Ryota ^a   Saguchi, Toru ^a   Akata, Soichi ^a   Tokuuye, Koichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

CT during arterial portography; CT hepatic arteriography; Diffusion weighted imaging; Hepatocellular carcinoma; Histological grade of differentiation

Indexed keywords

GADOXETIC ACID; IOMEPROL;

AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER ANGIOGRAPHY; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL PHLEBOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGNAL NOISE RATIO; T2 WEIGHTED IMAGING; TUMOR DIFFERENTIATION; TUMOR HEMODYNAMICS;

AGED; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM GRADING; NEOVASCULARIZATION, PATHOLOGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862518770     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2012.02374.x     Document Type: Article

References (35)

1. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161 (2): 401-7.
2. Kuroki Y, Nasu K, Kuroki S et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004; 3 (2): 79-85.
3. Tamai K, Koyama T, Saga T et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008; 18 (4): 723-30.
4. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 2009; 29 (2): 341-9.
5. Chen CY, Li CW, Kuo YT et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience. Radiology 2006; 239 (2): 448-56.
6. Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 2009; 193 (4): 1044-52.
7. Schraml C, Schwenzer NF, Martirosian P et al. Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results. AJR Am J Roentgenol 2009; 193 (4): W301-7.
8. Yu JS, Kim JH, Chung JJ, Kim KW. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. J Magn Reson Imaging 2009; 30 (1): 153-60.
9. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000; 43 (6): 828-36.
10. Nakajima Y, Shimamura T, Kamiyama T et al. Evaluation of surgical resection for small hepatocellular carcinomas. Am J Surg 1996; 171 (3): 360-3.
11. Jonas S, Bechstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33 (5): 1080-6.
12. Takayasu K, Muramatsu Y, Mizuguchi Y, Ojima H. CT imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology 2007; 72 (Suppl 1): 83-91.
13. Takayama T, Makuuchi M, Kojiro M et al. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol 2008; 15 (4): 972-8.
14. Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009; 44 (Suppl 19): 112-8.
15. Imai Y, Murakami T, Hori M et al. Hypervascular hepatocellular carcinoma: combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP. Hepatol Res 2008; 38 (2): 147-58.
16. Hayashi M, Matsui O, Ueda K et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999; 172 (4): 969-76.
17. Shinmura R, Matsui O, Kobayashi S et al. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 2005; 237 (2): 512-9.
18. Asayama Y, Yoshimitsu K, Nishihara Y et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. AJR Am J Roentgenol 2008; 190 (1): W28-34.
19. Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 2009; 193 (2): 438-44.
20. Hiwatashi A, Kinoshita T, Moritani T et al. Hypointensity on diffusion-weighted MRI of the brain related to T2 shortening and susceptibility effects. AJR Am J Roentgenol 2003; 181 (6): 1705-9.
21. Nasu K, Kuroki Y, Sekiguchi R, Nawano S. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006; 5 (3): 129-36.
22. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008; 18 (3): 486-92.
23. Kandpal H, Sharma R, Madhusudhan KS, Kapoor KS. Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values. AJR Am J Roentgenol 2009; 192 (4): 915-22.
24. Goshima S, Kanematsu M, Kondo H et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008; 28 (3): 691-7.
25. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183 (1): 59-64.
26. Heverhagen JT. Noise measurement and estimation in MR imaging experiments. Radiology 2007; 245 (3): 638-9.
27. Ebara M, Fukuda H, Kojima Y et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999; 210 (1): 81-8.
28. Muhi A, Ichikawa T, Motosugi U et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging 2009; 30 (5): 1005-11.
29. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006; 6: 135-43.
30. Hirohashi S, Ishak KG, Kojiro GM et al. Hepatocellular carcinoma. In: Hamilton SR, Aaltonen AL (eds). Pathology and Genetics of Tumors of the Digestive System. LARC Press, Lyon, 2000; 159-72.
31. Japan Lcsgo. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 5th edn. Kanehara-shuppan, Tokyo, 2008; 40-5.
32. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004; 10 (2 Suppl 1): S3-8.
33. Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 1990; 65 (9): 1994-2000.
34. Mitchell DG, Rubin R, Siegelman ES, Burk DL Jr, Rifkin MD. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 1991; 178 (1): 101-3.
35. Krinsky GA, Lee VS, Nguyen MT et al. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 2001; 218 (1): 47-53.